Sophia Genetics Raises FY2026 Sales Guidance from $94.000M-$96.000M to $96.000M vs $95.252M Est
Benzinga Newsdesk 5 hours ago
NewsGuidance
Sophia Genetics (NASDAQ:SOPH) raises FY2026 sales outlook from $94.000 million-$96.000 million to $96.000 million vs $95.252 million estimate.
Sophia Genetics (NASDAQ:SOPH) raises FY2026 sales outlook from $94.000 million-$96.000 million to $96.000 million vs $95.252 million estimate.